Richard A Colvin Bluebird Bio, Inc. (BLUE) insider trading activity

Richard A Colvin is Chief Medical Officer of bluebird bio, Inc.. Currently has a direct ownership of 0 shares of BLUE, which is worth approximately $0. The most recent transaction as insider was on Jun 02, 2025, when has been sold 6,666 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Richard A Colvin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 02 2025	SELL Sale (or disposition) back to the issuer	-	6,666 Reduced 100.0%	0 Common Stock
Jun 02 2025	BUY Grant, award, or other acquisition	-	2,500 Added 50.0%	2,500 Common Stock
May 30 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	3,552 Reduced 46.02%	4,166 Common Stock
Mar 03 2025	SELL Open market or private sale	$2,289 $3.92 p/Share	584 Reduced 7.13%	7,610 Common Stock
Feb 03 2025	SELL Open market or private sale	$472 $7.39 p/Share	64 Reduced 0.78%	8,194 Common Stock
Jan 06 2025	SELL Open market or private sale	$175 $9.24 p/Share	19 Reduced 0.23%	8,257 Common Stock
Dec 10 2024	SELL Open market or private sale	$1,186 $0.42 p/Share	2,824 Reduced 1.68%	165,544 Common Stock
Sep 30 2024	BUY Grant, award, or other acquisition	-	50,000 Added 22.9%	168,368 Common Stock
Mar 01 2024	SELL Open market or private sale	$10,358 $1.53 p/Share	6,770 Reduced 5.41%	118,368 Common Stock
Jan 05 2024	SELL Open market or private sale	$847 $1.42 p/Share	597 Reduced 0.47%	125,138 Common Stock
Nov 02 2023	SELL Open market or private sale	$6,982 $2.98 p/Share	2,343 Reduced 1.83%	125,735 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	55,000 Added 30.04%	128,078 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$7,356 $6.38 p/Share	1,153 Reduced 1.55%	73,078 Common Stock
Jan 11 2023	SELL Open market or private sale	$4,344 $7.8 p/Share	557 Reduced 0.74%	74,231 Common Stock
Nov 04 2022	SELL Open market or private sale	$1,397 $6.41 p/Share	218 Reduced 0.29%	74,788 Common Stock
Nov 01 2022	BUY Grant, award, or other acquisition	-	30,000 Added 28.57%	75,006 Common Stock

RAC

Richard A Colvin

Chief Medical Officer

Somerville, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLUE shares.

Notify only if

Value

Insider Trading

Get notified when an Bluebird Bio, Inc. insider buys or sells BLUE shares.

Notify only if

Operation

Value

Type

News

Receive news related to bluebird bio, Inc.

Track Activities on BLUE

Account